# Heme enhances B-cell proliferation and plasma cell formation through reduced p21 and Rb expression

**Authors:** Herbey O Padilla-Quirarte, Anna K Kania, Nicolas V Janto, Bagdeser Akdogan-Ozdilek, Sakeenah L Hicks, Carly J Roman, Mansi Gupta, Jeremy M Boss, Christopher D Scharer

PMC · DOI: 10.1093/jimmun/vkag025 · The Journal of Immunology Author Choice · 2026-03-18

## TL;DR

Heme boosts B-cell growth and plasma cell formation by reducing p21 and Rb, which helps cells progress through the cell cycle.

## Contribution

This study reveals a novel mechanism by which heme promotes plasma cell formation through p21 and Rb downregulation.

## Key findings

- Heme treatment increases gene expression and chromatin accessibility in B cells and plasma cells.
- Heme enhances B-cell proliferation and plasma cell formation by promoting G1 to S phase transition.
- Reduced p21 and Rb levels mediate heme's effect on cell cycle progression.

## Abstract

Antibodies are secreted by specialized antibody-secreting cells, also known as plasma cells (PCs), which differentiate from antigen-activated B cells. Antibodies are critical for protection against many types of infection and are correlates of vaccine efficacy. Iron metabolism is important for antibody responses, and heme (the major source of Fe2+) augments PC formation. However, the full spectrum of heme–molecular interactions and effects during B-cell differentiation are not fully understood. Here, we found that heme treatment of differentiating mouse B cells resulted in significant augmentation of the gene expression and chromatin accessibility landscape of both activated B cells and PC, with the largest effect occurring in genes regulating the G1 to S cell cycle transition. Consistent with this effect, naïve and memory B cells displayed enhanced proliferation and PC formation in the presence of heme. BrdU incorporation analysis revealed this was due to more DNA replication in later cell divisions, indicating more cells transitioning from G1 to S phase of the cell cycle. This occurred through diminished levels of p21 and Rb, which are key negative regulators of the G1/S cell cycle checkpoint. Altogether, this study shows that heme contributes to PC differentiation by regulating the G1 to S cell cycle phase transition through modulation of the p21-Rb regulatory axis.

## Linked entities

- **Genes:** CDKN1A (cyclin dependent kinase inhibitor 1A) [NCBI Gene 1026], RB1 (RB transcriptional corepressor 1) [NCBI Gene 5925]
- **Chemicals:** heme (PubChem CID 4973), Fe2+ (PubChem CID 23925)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Il2 (interleukin 2) [NCBI Gene 16183] {aka Il-2}, Trp53 (transformation related protein 53) [NCBI Gene 22059] {aka Tp53, bbl, bfy, bhy, p44, p53}, Ftl1 (ferritin light polypeptide 1) [NCBI Gene 14325] {aka Ftl, Ftl-1, L-ferritin}, Foxp3 (forkhead box P3) [NCBI Gene 20371] {aka JM2, scurfin, sf}, Bach2 (BTB and CNC homology, basic leucine zipper transcription factor 2) [NCBI Gene 12014] {aka E030004N02Rik}, Apc (APC, WNT signaling pathway regulator) [NCBI Gene 11789] {aka CC1, Min, mAPC}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, Pax5 (paired box 5) [NCBI Gene 18507] {aka BSAP, EBB-1, KLP, Pax-5}, PRDM1 (PR/SET domain 1) [NCBI Gene 639] {aka BLIMP-1, BLIMP1, PRDI-BF1}, Rb1 (RB transcriptional corepressor 1) [NCBI Gene 19645] {aka Rb, Rb-1, p110-RB1, pRb, pp105}, Irf4 (interferon regulatory factor 4) [NCBI Gene 16364] {aka IRF-4, LSIRF, NF-EM5, Spip}, Ccne1 (cyclin E1) [NCBI Gene 12447] {aka CycE1}, Nfe2l2 (nuclear factor, erythroid derived 2, like 2) [NCBI Gene 18024] {aka Nrf2}, IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, Trf (transferrin) [NCBI Gene 22041] {aka Cd176, HP, Tf, Tfn, hpx}, Il5 (interleukin 5) [NCBI Gene 16191] {aka Il-5}, Hmox1 (heme oxygenase 1) [NCBI Gene 15368] {aka D8Wsu38e, HO-1, HO1, Hemox, Hmox, Hsp32}, Irf8 (interferon regulatory factor 8) [NCBI Gene 15900] {aka ICSBP, IRF-8, Icsbp1, Myls}, Pcx (pyruvate carboxylase) [NCBI Gene 18563] {aka Pc, Pcb}, Slc48a1 (solute carrier family 48 (heme transporter), member 1) [NCBI Gene 67739] {aka 4930570C03Rik}, Prdm1 (PR domain containing 1, with ZNF domain) [NCBI Gene 12142] {aka Blimp-1, Blimp1, PRDI-BF1, ZNFPR1A1, b2b1765Clo}, Cd40lg (CD40 ligand) [NCBI Gene 21947] {aka CD154, CD40-L, Cd40l, HIGM1, IGM, IMD3}, Sdc1 (syndecan 1) [NCBI Gene 20969] {aka CD138, Sstn, Synd, Synd1, syn-1}, Itgam (integrin alpha M) [NCBI Gene 16409] {aka CD11b/CD18, CR3, CR3A, Cd11b, F730045J24Rik, Ly-40}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Aicda (activation-induced cytidine deaminase) [NCBI Gene 11628] {aka Aid, Arp2}, LOC641025 (Ig heavy chain Mem5-like) [NCBI Gene 641025] {aka CRP55H, IGHV, IgVH, Igh, Igm}, Kdm6b (KDM1 lysine (K)-specific demethylase 6B) [NCBI Gene 216850] {aka 1700064E03Rik, Jmjd3}, Slc40a1 (solute carrier family 40 (iron-regulated transporter), member 1) [NCBI Gene 53945] {aka Dusg, Fpn1, IREG1, MTP, MTP1, Ol5}, IL5 (interleukin 5) [NCBI Gene 3567] {aka EDF, IL-5, TRF}, Alb (albumin) [NCBI Gene 11657] {aka Alb-1, Alb1, BCL001, BCL002, BPL001}, Alas1 (aminolevulinic acid synthase 1) [NCBI Gene 11655] {aka ALAS, ALAS-N, Alas-1, Alas-h}, Hpx (hemopexin) [NCBI Gene 15458] {aka Hpxn, hx}, SPN (sialophorin) [NCBI Gene 6693] {aka CD43, GALGP, GPL115, LEU-22, LSN}, Rev3l (REV3 like, DNA directed polymerase zeta catalytic subunit) [NCBI Gene 19714] {aka Rev, Rev3, Sez4}, Adgre1 (adhesion G protein-coupled receptor E1) [NCBI Gene 13733] {aka DD7A5-7, EGF-TM7, Emr1, F4/80, Gpf480, Ly71}, Cd27 (CD27 antigen) [NCBI Gene 21940] {aka S152, Tnfrsf7, Tp55}, Il4 (interleukin 4) [NCBI Gene 16189] {aka BSF-1, Il-4}, F3 (coagulation factor III, tissue factor) [NCBI Gene 2152] {aka CD142, TF, TFA}, Thy1 (thymus cell antigen 1, theta) [NCBI Gene 21838] {aka CD90, T25, Thy-1, Thy-1.2, Thy1.1, Thy1.2}, Rel (Rel proto-oncogene, NFKB subunit) [NCBI Gene 19696] {aka c-Rel}, Igh-V7183 (immunoglobulin heavy chain (V7183 family)) [NCBI Gene 16059] {aka B9-scFv, IgG, IgH, IgVH1(VSG), VH7183, VI24H}, H3c7 (H3 clustered histone 7) [NCBI Gene 260423] {aka H3.2-221, H3c13, H3c14, H3c15, H3c2, H3c3}, Cdkn1a (cyclin dependent kinase inhibitor 1A) [NCBI Gene 12575] {aka CAP20, CDKI, CIP1, Cdkn1, P21, SDI1}, Tcf3 (transcription factor 3) [NCBI Gene 21423] {aka A1, ALF2, E12, E12/E47, E2A, E47}, Tfrc (transferrin receptor) [NCBI Gene 22042] {aka 2610028K12Rik, CD71, E430033M20Rik, Mtvr1, TFR, TFR1}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56717] {aka 2610315D21Rik, FRAP, FRAP2, Frap1, RAFT1, RAPT1}, Xcl1 (chemokine (C motif) ligand 1) [NCBI Gene 16963] {aka ATAC, LTN, Lptn, SCM-1, SCM-1a, Scyc1}, Ptprc (protein tyrosine phosphatase receptor type C) [NCBI Gene 19264] {aka B220, CD45R, Cd45, L-CA, Ly-5, Lyt-4}, CD40LG (CD40 ligand) [NCBI Gene 959] {aka CD154, CD40L, HIGM1, IGM, IMD3, T-BAM}, BACH2 (BACH transcriptional regulator 2) [NCBI Gene 60468] {aka BTBD25, IMD60}, Icosl (icos ligand) [NCBI Gene 50723] {aka B7-H2, B7RP-1, B7h, GI50, GL50, GL50-B}, Ighd (immunoglobulin heavy constant delta) [NCBI Gene 380797] {aka IgD, Igh-5}, ACTB (actin beta) [NCBI Gene 60] {aka BKRNS, BNS, BRWS1, CSMH, DDS1, PS1TP5BP1}, Slc11a2 (solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2) [NCBI Gene 18174] {aka DCT1, DMT1, Nramp2, mk, van}, Batf (basic leucine zipper transcription factor, ATF-like) [NCBI Gene 53314] {aka B-ATF, SFA-2}, Kdm6a (lysine (K)-specific demethylase 6A) [NCBI Gene 22289] {aka Utx}
- **Diseases:** malaria (MESH:D008288), PC (MESH:D015324), infection (MESH:D007239), PC (MESH:D007952), MBCs (MESH:D015448), measles (MESH:D008457), tumor (MESH:D009369), sickle cell disease (MESH:D000755), hemolysis (MESH:D006461), iron (MESH:D000090463), immune dysregulation (OMIM:614878)
- **Chemicals:** oxygen (MESH:D010100), KCl (MESH:D011189), acrylamide (MESH:D020106), glutamine (MESH:D005973), TD (MESH:C076628), sodium deoxycholate (MESH:D003840), streptomycin (MESH:D013307), Fe2+ (-), EDTA (MESH:D004492), glycerol (MESH:D005990), AF647 (MESH:C569686), KHCO3 (MESH:C026329), HEPES (MESH:D006531), SDS (MESH:D012967), Iron (MESH:D007501), penicillin (MESH:D010406), protoporphyrin IX (MESH:C028025), BD (MESH:C028491), PBS (MESH:D007854), 2-mercaptoethanol (MESH:D008623), isoflurane (MESH:D007530), NH4Cl (MESH:D000643), carbon monoxide (MESH:D002248), H2O (MESH:D014867), Heme (MESH:D006418), NaCl (MESH:D012965), glucose (MESH:D005947), digitonin (MESH:D004072), BrdU (MESH:D001973), biliverdin (MESH:D001664), Tween-20 (MESH:D011136), ATP (MESH:D000255), LPS (MESH:D008070)
- **Species:** Measles morbillivirus (no rank) [taxon 11234], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Alphainfluenzavirus (genus) [taxon 197911], H1N1 subtype (serotype) [taxon 114727]
- **Mutations:** 5 Cys-Pro
- **Cell lines:** /6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_5985), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13017971/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13017971/full.md

## References

69 references — full list in the complete paper: https://tomesphere.com/paper/PMC13017971/full.md

---
Source: https://tomesphere.com/paper/PMC13017971